698068 |
ONCOTARGETS AND THERAPY |
circHIPK3 (hsa_circ_0000284) Promotes Proliferation, Migration and Invasion of Breast Cancer Cells via miR-326 |
2021-06-01 |
10.2147/ott.s299190 |
Qi Liqiang, Sun Bo, Yang Beibei, Lu Su |
698067 |
ONCOTARGETS AND THERAPY |
Identification of Ten Mitosis Genes Associated with Tamoxifen Resistance in Breast Cancer |
2021-06-01 |
10.2147/ott.s290426 |
Sun Xi, Ding Shuning, Lu Shuangshuang, Wang Zheng, Chen Xiaosong, Shen Kunwei |
698066 |
ONCOTARGETS AND THERAPY |
Nuclear Factor-Kappa B1 Inhibits Early Apoptosis of Glioma Cells by Promoting the Expression of Bcl-2 [Retraction] |
2021-06-01 |
10.2147/ott.s326514 |
Yang Tian-quan, Chen Min, Wang Yong-qiang, Xu Wei, Han Yong, Xu Jin, Xiang Yong-jun, Yuan Bin, Wang Hang-zhou, Zhou You-xin |
698065 |
ONCOTARGETS AND THERAPY |
HS3ST2 and Its Related Molecules as Potential Biomarkers for Predicting Lymph Node Metastasis in Patients with Colorectal Cancer |
2021-06-01 |
10.2147/ott.s311038 |
Gao Guangyu, Shi Xinya, Shen Jiaofeng |
698064 |
ONCOTARGETS AND THERAPY |
PD-L1 Expressing Recurrent Clear Cell Carcinoma of the Vulva with Durable Partial Response to Pembrolizumab: A Case Report |
2021-06-01 |
10.2147/ott.s309661 |
Sachdeva Manavi, Ngoi Natalie YL, Lim Diana, Poon Michelle LM, Thian Yee Liang, Lim Yi Wan, Lim Siew Eng, Tong Pearl, Lum Jeffrey HY, Ng Joseph, Ilancheran Arunachalam, Domingo Efren J, Low Jeffrey JH, Tan David SP |
698063 |
ONCOTARGETS AND THERAPY |
Remarkable Response to Olaparib in a Patient with Combined Hepatocellular-Cholangiocarcinoma Harboring a Biallelic BRCA2 Mutation |
2021-06-01 |
10.2147/ott.s317514 |
Su Yu-Li, Ng Ca Tung, Jan Yi-Hua, Hsieh Yi-Lin, Wu Chia-Ling, Tan Kien Thiam |
698062 |
ONCOTARGETS AND THERAPY |
Intravascular Papillary Endothelial Hyperplasia Mimicking Vaginal Malignant Tumor in a Post-Radiotherapy Patient: A Case Report and Literature Review |
2021-06-01 |
10.2147/ott.s317160 |
Gong Ying-Xin, Xie Yu, Chen Limei, Sui Long |
698061 |
ONCOTARGETS AND THERAPY |
Fatty Acid–Binding Protein 4 (FABP4) Suppresses Proliferation and Migration of Endometrial Cancer Cells via PI3K/Akt Pathway |
2021-06-01 |
10.2147/ott.s311792 |
Wu Zimeng, Jeong Ji-Hak, Ren Chenchen, Yang Li, Ding Leilei, Li Feiyan, Jiang Dongyuan, Zhu Yuanhang, Lu Jie |
698060 |
ONCOTARGETS AND THERAPY |
Durable Response to Crizotinib in a Patient with Pulmonary Adenocarcinoma Harboring MET Intron 14 Mutation: A Case Report |
2021-06-01 |
10.2147/ott.s312889 |
Leyrat Brice, Durando Xavier, Veyssiere Hugo, Bernadach Maureen |
698059 |
ONCOTARGETS AND THERAPY |
The Association Between Radioiodine Refractory in Papillary Thyroid Carcinoma, Sodium/Iodide Symporter Expression, and BRAFV600E Mutation |
2021-06-01 |
10.2147/ott.s308910 |
Anekpuritanang Tauangtham, Uataya Maythad, Claimon Apichaya, Laokulrath Natthawadee, Pongsapich Warut, Pithuksurachai Paveena |